Gemmer Asset Management’s Gilead Sciences GILD Stock Holding History

Gemmer Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$449K	Sell	3,554 -152	-4%	-$20K	0.03%	120
2026 Q1	$516K	Buy	3,706 +96	+3%	+$13.4K	0.04%	106
2025 Q4	$443K	Sell	3,610 -18	-0.5%	-$2.19K	0.03%	118
2025 Q3	$403K	Hold	3,628	–	–	0.03%	116
2025 Q2	$402K	Buy	3,628 +1	+0%	+$106	0.04%	112
2025 Q1	$406K	Sell	3,627 -123	-3%	-$12.7K	0.04%	107
2024 Q4	$346K	Hold	3,750	–	–	0.03%	110
2024 Q3	$314K	Sell	3,750 -188	-5%	-$14.3K	0.03%	114
2024 Q2	$270K	Buy	+3,938	New	+$263K	0.03%	119
2022 Q2	–	Sell	-1,027	Closed	-$61K	–	494
2022 Q1	$61K	Sell	1,027 -25	-2%	-$1.6K	0.01%	232
2021 Q4	$76K	Buy	1,052 +3	+0.3%	+$207	0.01%	210
2021 Q3	$73K	Buy	1,049 +3	+0.3%	+$211	0.01%	190
2021 Q2	$72K	Buy	1,046 +23	+2%	+$1.54K	0.01%	214
2021 Q1	$66K	Buy	1,023 +1	+0.1%	+$64	0.01%	211
2020 Q4	$60K	Sell	1,022 -83	-8%	-$5.01K	0.01%	211
2020 Q3	$70K	Buy	1,105 +1	+0.1%	+$69	0.01%	162
2020 Q2	$85K	Buy	1,104 +112	+11%	+$8.58K	0.02%	141
2020 Q1	$74K	Buy	992 +147	+17%	+$10.2K	0.02%	135
2019 Q4	$55K	Sell	845 -12	-1%	-$781	0.01%	180
2019 Q3	$54K	Buy	857 +14	+2%	+$915	0.01%	185
2019 Q2	$57K	Buy	843 +1	+0.1%	+$66	0.02%	177
2019 Q1	$55K	Sell	842 -85	-9%	-$5.65K	0.02%	184
2018 Q4	$58K	Sell	927 -9	-1%	-$629	0.02%	156
2018 Q3	$72K	Sell	936 -98	-9%	-$7.4K	0.02%	144
2018 Q2	$73K	Sell	1,034 -6	-0.6%	-$424	0.03%	142
2018 Q1	$78K	Sell	1,040 -182	-15%	-$14.5K	0.03%	137
2017 Q4	$88K	Buy	1,222 +153	+14%	+$11.6K	0.03%	131
2017 Q3	$87K	Sell	1,069 -39	-4%	-$2.98K	0.03%	128
2017 Q2	$78K	Sell	1,108 -17	-2%	-$1.13K	0.03%	132
2017 Q1	$76K	Hold	1,125	–	–	0.03%	131
2016 Q4	$81K	Sell	1,125 -176	-14%	-$13.1K	0.04%	116
2016 Q3	$103K	Buy	1,301 +175	+16%	+$14.2K	0.05%	97
2016 Q2	$94K	Sell	1,126 -111	-9%	-$9.85K	0.05%	96
2016 Q1	$113K	Sell	1,237 -5	-0.4%	-$451	0.07%	99
2015 Q4	$126K	Buy	1,242 +3	+0.2%	+$312	0.07%	91
2015 Q3	$122K	Sell	1,239 -29	-2%	-$3.22K	0.08%	97
2015 Q2	$148K	Hold	1,268	–	–	0.09%	86
2015 Q1	$124K	Buy	1,268 +188	+17%	+$19.1K	0.08%	97
2014 Q4	$102K	Sell	1,080 -40	-4%	-$4.14K	0.07%	108
2014 Q3	$119K	Buy	1,120 +80	+8%	+$7.83K	0.08%	100
2014 Q2	$86K	Buy	1,040 +53	+5%	+$4.13K	0.06%	118
2014 Q1	$70K	Buy	+987	New	+$77.4K	0.05%	133

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Gemmer Asset Management's GILD Position: Q2 2026 in Review

Gemmer Asset Management reduced its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, selling an estimated $20K and leaving 3,554 shares worth $449K. The position accounts for 0.03% of the portfolio, ranked #120.

Gemmer Asset Management first reported a position in GILD in Q1 2014 and has held it in 42 quarters since. The position peaked at $516K in Q1 2026. 494 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Gemmer Asset Management held 3,554 shares of Gilead Sciences worth $449K as of Q2 2026.
Gemmer Asset Management sold 152 Gilead Sciences shares in Q2 2026, an estimated $20K.
Gilead Sciences made up 0.03% of Gemmer Asset Management's portfolio in Q2 2026, its #120 holding.
Gemmer Asset Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 42 quarters since.
Gemmer Asset Management's Gilead Sciences position peaked at $516K in Q1 2026.
494 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Gemmer Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.